We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2128:HKEXChina Lesso Group Holdings Limited Analysis

Data as of 2026-03-07 - not real-time

HK$6.02

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

China Lesso trades around HK$6.02, notably above its DCF‑derived fair value of roughly HK$2.28, implying a material discount to intrinsic worth. The stock enjoys a low trailing P/E of 9.7 versus an industry average of 29.4 and a solid dividend yield of 3.32%, but revenue has slipped 8% year‑on‑year and the company carries a high debt‑to‑equity ratio of 76.8, raising concerns about balance‑sheet resilience. Technicals show a bullish trend direction but a bearish MACD histogram and price sitting just below the 20‑day SMA, with support near HK$5.81 and resistance at HK$7.14, suggesting limited upside in the near term.
Given the low computed beta (0.09) and stable volume, the stock is not highly correlated with market swings, yet 30‑day volatility exceeds 50%, reflecting price sensitivity. The dividend payout ratio of 33% appears sustainable on the back of positive operating and free cash flow, offering income appeal despite the valuation premium.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above the identified support level of HK$5.81
  • Bearish MACD histogram indicating short‑term momentum weakness
  • Stable trading volume supporting liquidity

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Market price exceeds DCF fair value, suggesting limited upside
  • Strong dividend yield of 3.32% offsets valuation concerns
  • Negative revenue growth and high debt‑to‑equity ratio

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustainable dividend payout supported by positive cash flow
  • Low beta indicating limited systematic risk over longer horizons
  • Robust operating cash flow despite cyclical industry exposure

Key Metrics & Analysis

Financial Health

Revenue Growth-8.00%
Profit Margin6.50%
P/E Ratio9.7
ROE6.40%
ROA3.97%
Debt/Equity76.83
P/B Ratio0.7
Op. Cash FlowHK$2.8B
Free Cash FlowHK$1.6B
Industry P/E29.4

Technical Analysis

TrendBullish
RSI47.2
SupportHK$5.81
ResistanceHK$7.14
MA 20HK$6.41
MA 50HK$5.59
MA 200HK$4.81
MACDBearish
VolumeStable
Fear & Greed Index68.77

Valuation

Fair ValueHK$2.28
Target PriceHK$5.53
Upside/Downside-8.11%
GradeOvervalued
TypeValue
Dividend Yield3.32%

Risk Assessment

Beta0.09
Volatility54.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.